Jianming Zeng

Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12.

Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12.

Journal: EMBO reports
Published: July 20, 2023

Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling.

Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling.

Journal: Science advances
Published: January 20, 2023

Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice.

Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific Smad4/Pten mutant mice.

Journal: International journal of biological sciences
Published: September 22, 2021

Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.

Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.

Journal: Theranostics
Published: June 17, 2021

Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.

Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2021

Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.

Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.

Journal: Theranostics
Published: April 24, 2020

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.

Journal: Theranostics
Published: March 29, 2020

Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor.

Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor.

Journal: Nature communications
Published: December 03, 2019

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics.

Journal: Nature communications
Published: November 04, 2019

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

Journal: Nature communications
Published: June 11, 2019
Showing 1-10 of 10

Last Updated: 09/26/2026